Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics & Global Health 2018

Point-of-Care Diagnostics & Global Health 2018



Moderator

Leanna Levine

Leanna Levine
Founder & CEO, ALine, Inc.

Keynote Speakers


Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London


John Brennan
Professor and Director, Biointerfaces Institute, McMaster University


Hsueh-Chia Chang
Bayer Professor of Chemical and Biomolecular Engineering, University of Notre Dame, Interim Chief Technology Officer, Aopia Biosciences


Dino Di Carlo
Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Vice Chair of Bioengineering, University of California-Los Angeles


Michael Heller
Professor, Dept Bioengineering, University of California-San Diego


Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore


Arben Merkoçi
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)


Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas


Bernhard Weigl
Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund

Overview

Welcome to the SELECTBIO Point-of-Care Diagnostics and Global Health 2018.

This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.  Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have full access to the co-located parallel conferences:
  • Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2018
  • Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2018
  • Point-of-Care Diagnostics and Global Health 2018
  • Single Cell Analysis Summit 2018

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • Emerging Technologies and Emerging Companies Showcase
  • Global Health and Emerging Viral Diseases such as Ebola and Zika
  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
    • Innovations in Technology Development
  • POC Diagnostics for Global Health: A Worldwide Perspective
    • Low-Cost POC Devices for Deployment Worldwide
    • POC Diagnostics in Resource-Limited Settings
  • POC Diagnostics in Infectious Disease Testing

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Chaminda Salgado, Cell & Gene Therapy Medicinal Process Delivery Leader, GlaxoSmithKline
Charles Daitch, CEO, Akonni Biosystems Inc.
Amy Adelberger, Founder and CEO, Global Impact Advisors
Robert Meagher, Principal Member of the Technical Staff, Sandia National Laboratories
Paul Yager, Professor, Department of Bioengineering, University of Washington and CSO, UbiDX, Inc.
Claudio Parolo, Research Fellow, University of California-Santa Barbara
Alexandra Perebikovsky, Researcher, University of California-Irvine
Hsuan-Yu Leu, Researcher, University of Utah
Jim Gallarda, Senior Program Officer, Bill & Melinda Gates Foundation


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks